UCSF

ZINC00537805

Substance Information

In ZINC since Heavy atoms Benign functionality
July 24th, 2004 33 No

CAS Numbers: 10238-21-8 , 23047-14-5 , [10238-21-8]

Other Names:

1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea

1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide; Adiab; Apo

1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea; 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea; 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide; Glyburide

1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea

10238-21-8

10238-21-8; C07022; Glibenclamide; Glyburide

10238-21-8; CPD000058229; Glyburide; SAM002564212

10238-21-8; D00336; Diabeta (TN); Glibenclamide (JP16/INN); Glyburide (USP); Glynase (TN); Micronase (TN)

10238-21-8; Glibenclamide; Prestwick_569

5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)aminosulfonyl]phenyl}ethyl)-2-methoxybenzamide

5-chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide

5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide

5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide

5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide

AB00051949

Abbenclamide

AC1L1G1Q

AC1Q44V7

Adiab

AKOS001487495

Apo-Glibenclamide

Apo-Glibenclamide;Glibenclamida [INN-Spanish];Glibenclamide;Glibenclamidum [INN-Latin]

Azuglucon

BAN

Bastiverit

Benclamin

Betanase

Betanese 5

BIDD:GT0239

Bio-0156

Bio1_000076

Bio1_000565

Bio1_001054

Bio2_000071

Bio2_000551

BPBio1_000344

BRD-K36927236-001-06-0

BRN 2230085

BSPBio_000312

BSPBio_001351

BSPBio_003053

C07022

C23H28ClN3O5S

C23H28ClN3O5S.C4H11N5.Cl; GLUCOVANCE; GLYBURIDE; METFORMIN HYDROCHLORIDE; LS-178556

Calabren

CAS-10238-21-8

CBiol_001790

CHEBI:5441

CHEMBL472

CID3488

CPD000058229

CPD000058229; Glybenclamide; Glyburide; SAM002564212

Cytagon

D00336

D005905

Daonil

DAP000037

DB01016

DCF

Debtan

Dia-basan

DiaBeta

Diabeta (TN)

Diabeta; Glynase; Micronase

Diabetamide

Diabiphage

Dibelet

DivK1c_000481

Duraglucon

EINECS 233-570-6

EU-0100499

Euclamin

Euglucan

Euglucon

Euglucon 5

Euglucon N

Euglykon

G 0639

G0639_SIAL

G0639_SIGMA

G2539_SIAL

GBN 5

Gen-Glybe

Gewaglucon

GIBENCLAMIDE

Gilemal

Glamide

Glibadone

Gliban

Gliben

Gliben-Puren N

Glibenbeta

Glibenclamid AL

Glibenclamid Basics

Glibenclamid Fabra

Glibenclamid Genericon

Glibenclamid Heumann

Glibenclamid Riker M

Glibenclamid Riker M.

Glibenclamid-Cophar

Glibenclamid-Ratiopharm

Glibenclamida

Glibenclamida [INN-Spanish]

glibenclamida; glibenclamide; glibenclamidum

Glibenclamide

Glibenclamide (BAN

Glibenclamide (DCF

Glibenclamide (JP15/INN)

Glibenclamide potassium salt

Glibenclamide, Glycron, Glynase, Micronase, Daonil, Semi-Daonil, Euglucon, Delmide

Glibenclamidum

Glibenclamidum [INN-Latin]

Glibenclamidum [INN-Latin];Glibenclamida [INN-Spanish];Glibenclamide;Apo-Glibenclamide

Glibenil

Glibens

Glibesyn

Glibet

Glibetic

Glibil

Gliboral

Glicem

Glidiabet

Glimel

Glimide

Glimidstata

Glisulin

Glitisol

Glubate

Gluben

Gluco-Tablimen

Glucobene

Glucohexal

Glucolon

Glucomid

Glucoremed

Glucoven

Glyben

Glybenclamide

Glybenzcyclamide

Glybenzcyclamide, 99%

Glyburide (Diabeta)

Glyburide (FDA

Glyburide (Glibenclamide)

Glyburide (micronized)

Glyburide (USP)

Glyburide [USAN]

Glycolande

Glycomin

Glynase

Glynase (TN)

Glynase PresTab

HB 419

HB 419; HB-419; U-26452

HB 420

HB-419

HB-420

HB419

HB420

Hemi-Daonil

Hexaglucon

HMS1361D13

HMS1568P14

HMS1791D13

HMS1922L08

HMS1989D13

HMS2089L06

HMS2093P04

HMS501I03

Humedia

I06-0716

IDI1_000481

IDI1_033821

INN

JAN)

JAN); Glyburide (FDA

KBio1_000481

KBio2_000071

KBio2_000730

KBio2_002639

KBio2_003298

KBio2_005207

KBio2_005866

KBio3_000141

KBio3_000142

KBio3_002273

KBioGR_000071

KBioGR_001897

KBioSS_000071

KBioSS_000730

Lederglib

Libanil

Lisaglucon

LS-159295

Malix

Maninil

Med-Glionil

Melix

MFCD00056625

Micronase

Micronase (TN)

Micronized glyburide

Miglucan

MLS000069721

MLS001077262

MolPort-000-784-850

N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea

N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea

N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea

N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide

Nadib

NCGC00015467-01

NCGC00015467-02

NCGC00015467-06

NCGC00015467-16

NCGC00016689-01

NCGC00023447-02

NCGC00023447-04

NCGC00023447-05

NCGC00023447-06

NCGC00023447-07

NCGC00023447-08

NCGC00023447-09

NCGC00023447-10

NCGC00023447-11

NCGC00023447-12

Neogluconin

NINDS_000481

Norglicem 5

Normoglucon

Novo-Glyburide

Oprea1_764617

Orabetic

Pira

Praeciglucon

PresTab

Prestwick0_000316

Prestwick1_000316

Prestwick2_000316

Prestwick3_000316

Prestwick_569

Probes1_000431

Probes2_000378

Prodiabet

Renabetic

S1716_Selleck

SAM002564212

Semi-Daonil

Semi-Euglucon

Semi-Gliben-Puren N

SMR000058229

SPBio_001831

SPBio_002531

SPECTRUM2300229

Spectrum2_001816

Spectrum3_001327

Spectrum4_001199

Spectrum5_001631

Spectrum_000250

SR-01000000196-5

STK362992

Sugril

Suraben

Tiabet

Tocris-0911

U 26452

U-26452

UNII-SX6K58TVWC

UPCMLD-DP006

UPCMLD-DP006:001

UR 606

Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-

Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-

USAN

USP)

USP); Glibenclamide (BAN

Yuglucon

ZINC00537805

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.40 5.51 -67.24 2 8 -1 120 493.005 9
Ref Reference (pH 7) 4.40 4.95 -23.65 3 8 0 117 494.013 9
Lo Low (pH 4.5-6) 4.77 7.45 -21.59 3 8 0 114 494.013 8

Vendor Notes

Note Type Comments Provided By
Melting_Point 171-174? Alfa-Aesar
Melting_Point 171-174° Alfa-Aesar
ALOGPS_SOLUBILITY 2.06e-03 g/l DrugBank-approved
Purity >99% Fluorochem
UniProt Database Links AB5C_ARATH; CISD1_HUMAN; TRPM4_MOUSE ChEBI
Therapy Antidiabetic agent which blocks pancreatic ATP-dependent K+ channels resulting in an increase in intracellular Ca2+ and SMDC Iconix
biological_use Antidiabetic drug (type II diabetes) IBScreen Bioactives
therap antihyperglycemic MicroSource Spectrum
mechanism ATP-sensitive potassium channels ZereneX Building Blocks
mechanism ATP-sensitive potassium channels (KATP) blocker in pancreatic beta cells IBScreen Bioactives
Patent Database Links EP1201649; EP1201660; EP1354882; EP1493443; EP1514550; EP1559710; EP1611879; EP1629835; EP1741713; EP1743655; EP1785144; EP1808163; EP1832291; EP1832576; EP1862450; EP1884244; EP1894567; EP1897547; EP1939188; EP1946777; EP1972336; EP1997489; EP1997533; US ChEBI
biological_use Inhibits drug-induced coronary vasodilation IBScreen Bioactives IBScreen Bioactives
biological_use Inhibits drug-induced coronary vasodilation; Antidiabetic drug ZereneX Building Blocks
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : G-2693; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
Target Potassium Channel Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: G-2693; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem
Indications type II diabetes KeyOrganics Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
AMPC-2-B Beta-lactamase (cluster #2 Of 6), Bacterial Bacteria 49 0.31 Binding ≤ 10μM
ABCC8-1-E Sulfonylurea Receptor 1 (cluster #1 Of 1), Eukaryotic Eukaryotes 4 0.36 Binding ≤ 10μM
ABCC9-1-E Sulfonylurea Receptor 2 (cluster #1 Of 2), Eukaryotic Eukaryotes 1 0.38 Binding ≤ 10μM
CTRA-3-E Alpha-chymotrypsin (cluster #3 Of 4), Eukaryotic Eukaryotes 8 0.34 Binding ≤ 10μM
IRK11-1-E Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11 (cluster #1 Of 2), Eukaryotic Eukaryotes 4 0.36 Binding ≤ 10μM
IRK8-1-E Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8 (cluster #1 Of 1), Eukaryotic Eukaryotes 1 0.38 Binding ≤ 10μM
KCND3-1-E Voltage-gated Potassium Channel Subunit Kv4.3 (cluster #1 Of 1), Eukaryotic Eukaryotes 1 0.38 Binding ≤ 10μM
MDHM-1-E Malate Dehydrogenase, Mitochondrial (cluster #1 Of 2), Eukaryotic Eukaryotes 3 0.36 Binding ≤ 10μM
Z50512-1-O Cavia Porcellus (cluster #1 Of 7), Other Other 8 0.34 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 2 0.37 Functional ≤ 10μM
Z81047-1-O Human T-cell Line (cluster #1 Of 2), Other Other 1000 0.25 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
CTRA_BOVIN P00766 Alpha-chymotrypsin, Bovin 6 0.35 Binding ≤ 1μM
AMPC_ENTCL P05364 Beta-lactamase, Entcl 49 0.31 Binding ≤ 1μM
AMPC_ECOLI P00811 Beta-lactamase, Ecoli 5 0.35 Binding ≤ 1μM
MDHM_PIG P00346 Malate Dehydrogenase Mitochondrial, Pig 24 0.32 Binding ≤ 1μM
IRK11_HUMAN Q14654 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human 130 0.29 Binding ≤ 1μM
IRK11_RAT P70673 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Rat 0.608 0.39 Binding ≤ 1μM
IRK8_RAT Q63664 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8, Rat 0.608 0.39 Binding ≤ 1μM
ABCC8_HUMAN Q09428 Sulfonylurea Receptor 1, Human 4.3 0.35 Binding ≤ 1μM
ABCC9_HUMAN O60706 Sulfonylurea Receptor 2, Human 130 0.29 Binding ≤ 1μM
ABCC9_RAT Q63563 Sulfonylurea Receptor 2, Rat 0.608 0.39 Binding ≤ 1μM
KCND3_HUMAN Q9UK17 Voltage-gated Potassium Channel Subunit Kv4.3, Human 0.608 0.39 Binding ≤ 1μM
CTRA_BOVIN P00766 Alpha-chymotrypsin, Bovin 6 0.35 Binding ≤ 10μM
AMPC_ENTCL P05364 Beta-lactamase, Entcl 49 0.31 Binding ≤ 10μM
AMPC_ECOLI P00811 Beta-lactamase, Ecoli 5 0.35 Binding ≤ 10μM
MDHM_PIG P00346 Malate Dehydrogenase Mitochondrial, Pig 24 0.32 Binding ≤ 10μM
IRK11_HUMAN Q14654 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human 130 0.29 Binding ≤ 10μM
IRK11_RAT P70673 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Rat 0.608 0.39 Binding ≤ 10μM
IRK8_RAT Q63664 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 8, Rat 0.608 0.39 Binding ≤ 10μM
ABCC8_HUMAN Q09428 Sulfonylurea Receptor 1, Human 4.3 0.35 Binding ≤ 10μM
ABCC9_RAT Q63563 Sulfonylurea Receptor 2, Rat 0.608 0.39 Binding ≤ 10μM
ABCC9_HUMAN O60706 Sulfonylurea Receptor 2, Human 130 0.29 Binding ≤ 10μM
KCND3_HUMAN Q9UK17 Voltage-gated Potassium Channel Subunit Kv4.3, Human 0.608 0.39 Binding ≤ 10μM
Z50512 Z50512 Cavia Porcellus 8 0.34 Functional ≤ 10μM
Z81047 Z81047 Human T-cell Line 1000 0.25 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 1.6 0.37 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
ABC-family proteins mediated transport
ATP sensitive Potassium channels
Regulation of insulin secretion
Voltage gated Potassium channels

Analogs ( Draw Identity 99% 90% 80% 70% )